iSTAR Medical Company Profile
iSTAR Medical, founded in 2010 and now an AbbVie subsidiary based in Belgium with 60 employees, develops innovative ophthalmic implants with anti-fibrotic and anti-inflammatory properties to treat glaucoma by enhancing natural fluid outflow and reducing intraocular pressure, has raised $84.5M through multiple funding rounds including a $60M acquisition deal in 2022, holds 44 patent documents (27 granted), and competes with companies like Ocular Therapeutix.
Company Overview
iSTAR Medical is a developer of innovative ophthalmic implants designed to treat glaucoma. The company's implants exhibit anti-fibrotic and anti-inflammatory properties and are designed to enhance natural fluid outflow, reducing intraocular pressure and the need for medication. The implants bio-integrate with surrounding tissue, limiting inflammation, fibrosis, and subsequent complications, providing glaucoma patients with an advanced, safe, and effective treatment alternative.
- Year Founded: 2010
- Status: Acquired/Merged (Operating Subsidiary)
- Employees: 60
- Headquarters: Avenue Sabin, 6, 1300 Wavre, Belgium
- Primary Industry: Therapeutic Devices
- Parent Company: AbbVie
- Vertical: HealthTech
- Financing Status: Formerly VC-backed
Valuation & Funding
- Total Funding Raised: $84.5M
- Latest Deal Type: Merger/Acquisition
- Latest Deal Amount: $60M (30-Jun-2022)
- Previous Funding Rounds:
- Debt - General (30-Jul-2021)
- Later Stage VC (Series C, 05-Sep-2019)
- Later Stage VC (Series B, 12-Apr-2016)
- Early Stage VC (Series A, 14-Oct-2014, $5.09M)
- Grant (14-Sep-2012, $4.54M)
Cap Table (Selected)
- Privilege Shares: 50,000 at $236.49 (16.51% owned)
- Privilege Shares: 40,000 at $177.37 (13.21% owned)
Competitors
- Ocular Therapeutix (Formerly VC-backed, Bedford, MA)
Patents
- Total Documents (Applications and Grants): 44
- Granted: 27
- Pending: 11
Recent Patent Activity (Selected)
- AU-2023232241-A1: Delivery shaft assembly for delivery of an implant (Pending, 09-Mar-2022)
- EP-4489701-A1/B1/C0: Delivery shaft assembly for delivery of an implant (Active, 09-Mar-2022)
- ES-3057785-T3: Delivery shaft assembly for delivery of an implant (Active, 09-Mar-2022, Technology: A61F9/00781)
Former Investors (Selected)
- AWEX (Corporation)
- BNP Paribas Fortis Private Equity (Growth/Expansion)
- BioWin (Other)
- Capricorn Partners (Venture Capital)
- Demea Sustainable Investment (PE/Buyout)
Affiliates
- Subsidiary: Youco F21-H379 Vorrats (Frankfurt A. Main, Germany, Founded 2021)
FAQs
When was iSTAR Medical founded?
iSTAR Medical was founded in 2010.
Where is iSTAR Medical headquartered?
iSTAR Medical is headquartered in Wavre, Belgium.
What is the size of iSTAR Medical?
iSTAR Medical has 60 total employees.
What industry is iSTAR Medical in?
iSTAR Medical’s primary industry is Therapeutic Devices.
Is iSTAR Medical a private or public company?
iSTAR Medical is a Private company.
How much funding has iSTAR Medical raised over time?
iSTAR Medical has raised $84.5M.
Who are iSTAR Medical’s investors?
AWEX, BNP Paribas Fortis Private Equity, BioWin, Capricorn Partners, and Demea Sustainable Investment are among the investors who have invested in iSTAR Medical.
Who are iSTAR Medical’s competitors?
Ocular Therapeutix is a competitor of iSTAR Medical.
When was iSTAR Medical acquired?
iSTAR Medical was acquired on 30-Jun-2022.
Who acquired iSTAR Medical?
iSTAR Medical was acquired by AbbVie.